News

28 February 2019

Second Set of “Semi-Identical Twins” Identified

Twins born in Australia have become the second-ever-identified pair of “semi-identical” twins, and the first to be detected before they were born. Such cases come about when twins receive 100% identical genes from their mother, but not from their father.

27 February 2019

First Common Risk Genes for Autism Discovered

Researchers from the Broad Institute in the US and Danish iPSYCH project have discovered the first common genetic risk variants for autism and uncovered genetic differences in clinical subgroups of autism.

26 February 2019

How to Recruit a High-Performing Apprentice: Anglia Ruskin Panel Event

In September 2019, Anglia Ruskin University’s (ARU’s) Cambridge campus will begin the first year of its new – and currently unique in the UK – Data Scientist Degree Apprenticeship for the bioinformatics profession. Ahead of this, ARU and the Wellcome Sanger Institute have set up a “Lunch and Learn” panel event for hiring managers and talent acquisition specialists, looking at how they can best recruit and support top apprentices.

26 February 2019

Neuron-Optimised CRISPR Can Manipulate Neuron Gene Expression for First Time

A neuron-optimised CRISPR-Cas9 activation system has been used by scientists to regulate genes in a rat brain for the first time. This technique could lead to researchers being able to probe genetic influences on brain health and disease in model organisms which more closely resemble humans.

25 February 2019

New “Hit and Run” CRISPR Delivery System Improves Efficiency

Researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) have determined a new way to deliver DNA editing tools so that the presence of their proteins in cells is reduced, in what they have called a “hit and run” approach.

18 February 2019

Drug Combination Shows Survival Promise for Kidney Cancer Patients

A combination of immunotherapy drug avelumab and targeted agent axitinib has been seen to increases progression-free survival in patients with metastatic kidney cancer, scientists from the Dana-Farber Institute have reported following a phase 3 clinical trial.

18 February 2019

Bio-Rad’s PCR-Based Test for CML Finds FDA Approval

Global life science researcher Bio-Rad has announced that its droplet digital PCR-based test for chronic myeloid leukaemia (CML), the first of its kind, has been cleared by the FDA. The test quantifies BCR-ABL, the gene fusion which causes CML, in the blood.